NTI Co-Chair and CEO Ernest Moniz remarks on Russia’s suspension of the New START treaty and the one year anniversary of the war in Ukraine
At this year's Munich Security Conference, NTI is hosting two official side events: one about the importance of global nuclear “fail-safe” measures and one about preventing bioweapons and catastrophic accidents.
Shirley Ann Jackson, Ph.D., a renowned educator and national leader in scientific research and technology, is joining NTI’s Board of Directors, NTI Co-Chairs Ernest J. Moniz, Sam Nunn, and Ted Turner announced.
NTI is pleased to announce that it has awarded the first Berls Fund grant of $25,000 to the Younger Generation Leaders Network on Euro-Atlantic Security (YGLN).
NTI is pleased to announce the appointment of Nathan A. Paxton as a senior director on NTI’s Global Biological Policy and Programs team (NTI | bio).
The International Partnership for Nuclear Disarmament Verification (IPNDV) held its annual plenary meeting in person from December 5-9, 2022, in Sydney, Australia. This meeting of the IPNDV was generously hosted by the Australian Safeguards and Non-Proliferation Office (ASNO).
NTI | bio experts contributed to the 9th Biological Weapons Convention Review Conference in Geneva.
NTI | bio partnered with Carnegie India as a "knowledge partner" for the 2022 Global Technology Summit and led two sessions on global biosecurity and biosafety.
NTI | bio convened experts from around the world from governments, industry, and civil society in Cape Town, South Africa to discuss emerging biological risks and offer actions to address them.
NTI and ENEC signed a three-year agreement for a new collaborative nuclear security project, “Building a Cooperative Approach to the Future of Nuclear Energy Development and Nonproliferation.”
Sign up for regular updates on innovative, real-world solutions to existential threats.
